Company intelligence / Profile preview

MDDx

San Francisco/San Francisco Bay Area, California, United Statesmddxinc.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

MDDx is developing and commercializing advanced diagnostic tests to address critical gaps in early detection of gynecologic cancers and other major women’s health issues. Their solutions aim to provide faster and more accurate diagnoses compared to current standards, with a focus on non-invasive testing options that improve sensitivity and specificity over existing ctDNA-based approaches. The company is clinician-led with a mission to transform care pathways for millions of at-risk women.

Therapeutic areas: Women's HealthOncology
Modalities: Diagnostic test
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on MDDx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MDDx.

Explore the full profile